MicroRNA-7 Inhibits Multiple Oncogenic Pathways to Suppress HER2Δ16 Mediated Breast Tumorigenesis and Reverse Trastuzumab Resistance
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-7 Inhibits Multiple Oncogenic Pathways to Suppress HER2Δ16 Mediated Breast Tumorigenesis and Reverse Trastuzumab Resistance
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 12, Pages e114419
Publisher
Public Library of Science (PLoS)
Online
2014-12-23
DOI
10.1371/journal.pone.0114419
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- JARID1B Is a Luminal Lineage-Driving Oncogene in Breast Cancer
- (2014) Shoji Yamamoto et al. CANCER CELL
- Identification of quinones as HER2 inhibitors for the treatment of trastuzumab resistant breast cancer
- (2013) Jayalakshmi Sridhar et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- miR-7 Suppresses Brain Metastasis of Breast Cancer Stem-Like Cells By Modulating KLF4
- (2013) H. Okuda et al. CANCER RESEARCH
- Control of metastatic progression by microRNA regulatory networks
- (2013) Nora Pencheva et al. NATURE CELL BIOLOGY
- MiR-7 Triggers Cell Cycle Arrest at the G1/S Transition by Targeting Multiple Genes Including Skp2 and Psme3
- (2013) Noelia Sanchez et al. PLoS One
- Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer
- (2012) Hongjiang Wang et al. PLoS One
- MicroRNA-7 Inhibits Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer Cells via Targeting FAK Expression
- (2012) Xiangjun Kong et al. PLoS One
- Jumonji/ARID1 B (JARID1B) Protein Promotes Breast Tumor Cell Cycle Progression through Epigenetic Repression of MicroRNA let-7e
- (2011) Doyel Mitra et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways
- (2011) Siyuan Zhang et al. NATURE MEDICINE
- Treatment of HER2-positive breast cancer: current status and future perspectives
- (2011) Carlos L. Arteaga et al. Nature Reviews Clinical Oncology
- MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells
- (2010) Lu Jiang et al. BIOCHEMICAL JOURNAL
- Oncogenic HER2Δ16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors
- (2010) Diana M. Cittelly et al. CARCINOGENESIS
- MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression
- (2010) Ming Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An oncogenic isoform of HER2 associated with locally disseminated breast cancer and trastuzumab resistance
- (2009) D. Mitra et al. MOLECULAR CANCER THERAPEUTICS
- The HER4/4ICD Estrogen Receptor Coactivator and BH3-Only Protein Is an Effector of Tamoxifen-Induced Apoptosis
- (2008) A. Naresh et al. CANCER RESEARCH
- microRNA-7 Inhibits the Epidermal Growth Factor Receptor and the Akt Pathway and Is Down-regulated in Glioblastoma
- (2008) B. Kefas et al. CANCER RESEARCH
- MicroRNA-7, a Homeobox D10 Target, Inhibits p21-Activated Kinase 1 and Regulates Its Functions
- (2008) S. D. N. Reddy et al. CANCER RESEARCH
- Regulation of Epidermal Growth Factor Receptor Signaling in Human Cancer Cells by MicroRNA-7
- (2008) Rebecca J. Webster et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Small is beautiful: microRNAs and breast cancer-where are we now?
- (2008) ET Verghese et al. JOURNAL OF PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started